NISCAIR Online Periodicals Repository

NISCAIR ONLINE PERIODICALS REPOSITORY (NOPR)  >
NISCAIR PUBLICATIONS >
Research Journals >
Journal of Intellectual Property Rights (JIPR) >
JIPR Vol.07 [2002] >
JIPR Vol.07(2) [March 2002] >


Title: Intellectual Property Rights and Assessment of the Raw Materials (Crude Drugs) Used in Indian Systems of Medicine
Authors: Ahmad, R U
Issue Date: Mar-2002
Publisher: CSIR
Abstract:  There are two types of Ayurvedic medicines prepared in the country. First is the classical drugs (based on classical literature of the Ayurvedic System of Medicine as given in Schedule-A of the Drug & Cosmetics Act, 1940). Second is the `patent and proprietary’ (P.P.) medicine manufactured by the pharmaceutical industry of the Indian Systems of Medicine (ISM) on their own developed formulations (by adding or deleting in the original classical formulations). In all these formulations, 90% drugs of plant origin are used in their own natural forms as roots, stems, leaves, fruits, and their modified structures and their derivatives like gums, exudates, etc. Since these crude drugs raw material may not have been evaluated scientifically on botanical, pharmacognostical, chemical and pharmacological parameters, etc. it is therefore, necessary to screen them out for various ailments. Pharmaceutical industry of ISM in the country is very large and manufacturing its drugs on the basis of licence issued by the Drug Control Authorities of the respective States. Position of drugs of ISM as to how they are procured, obtained from various resources in the country is not known exactly. The activities attributed to a single plant for various ailments are quite scanty. Their trade history, supply and demand, involvement of national level institutions and their trade market is also not authentically established. Government of India is busy in laying down its standards in the form of pharmacopoeial monographs for quality control purposes. Looking into all these aspects it is necessary that the aspects of intellectual property rights and assessment of raw material (crude drugs) used in ISM is given top priority. The impact of intellectual property-related issues like TRIPS Agreement on the status of crude drugs used in ISM has been discussed. The format proposed by the Forum of Parliamentarians on Intellectual Property Rights is given in the paper and the proposals are given by the author under each item for their adherence to solve the patenting problem of the raw material of ISM industry in the country.
Page(s): 143-150
ISSN: 0975-1076 (Online); 0971-7544 (Print)
Source:JIPR Vol.07(2) [March 2002]

Files in This Item:

File Description SizeFormat
JIPR 7(2) 143-150.pdf41.28 kBAdobe PDFView/Open
 Current Page Visits: 643 
Recommend this item

 

National Knowledge Resources Consortium |  NISCAIR Website |  Contact us |  Feedback

Disclaimer: NISCAIR assumes no responsibility for the statements and opinions advanced by contributors. The editorial staff in its work of examining papers received for publication is helped, in an honorary capacity, by many distinguished engineers and scientists.

CC License Except where otherwise noted, the Articles on this site are licensed under Creative Commons License: CC Attribution-Noncommercial-No Derivative Works 2.5 India

Copyright © 2012 The Council of Scientific and Industrial Research, New Delhi. All rights reserved.

Powered by DSpace Copyright © 2002-2007 MIT and Hewlett-Packard | Compliant to OAI-PMH V 2.0

Home Page Total Visits: 638720 since 06-Feb-2009  Last updated on 15-Dec-2014Webmaster: nopr@niscair.res.in